Lantheus Holdings, Inc. Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities
Lantheus Holdings, Inc. (LNTH) reported Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities of 1.03 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities · last filed 2026-08-06
- Lantheus Holdings, Inc. incremental common shares attributable to dilutive effect of conversion of debt securities for the quarter ending 2026-06-30 was 1.03M shares, a 57.23% increase year-over-year.
- Lantheus Holdings, Inc. incremental common shares attributable to dilutive effect of conversion of debt securities for the quarter ending 2026-03-31 was 0.00 shares, a 100.00% decline year-over-year.
- Lantheus Holdings, Inc. incremental common shares attributable to dilutive effect of conversion of debt securities for the quarter ending 2025-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- Lantheus Holdings, Inc. incremental common shares attributable to dilutive effect of conversion of debt securities for the quarter ending 2025-06-30 was 657.00K shares.
- Lantheus Holdings, Inc. incremental common shares attributable to dilutive effect of conversion of debt securities for fiscal 2025 was 0.00 shares, a 100.00% decline from fiscal 2024.
- Lantheus Holdings, Inc. incremental common shares attributable to dilutive effect of conversion of debt securities for fiscal 2024 was 742.00K shares, a 272.86% increase from fiscal 2023.
- Lantheus Holdings, Inc. incremental common shares attributable to dilutive effect of conversion of debt securities for fiscal 2023 was 199.00K shares.
- Lantheus Holdings, Inc. incremental common shares attributable to dilutive effect of conversion of debt securities for fiscal 2022 was 0.00 shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 3 month | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 6 month | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 9 month | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 12 month |
|---|---|---|---|---|
| 2026-06-30 | 1.03M shares 10-Q · filed 2026-08-06 | 240.00K shares 10-Q · filed 2026-08-06 | ||
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | 0.00 shares 10-K · filed 2026-02-26 | |||
| 2025-09-30 | 0.00 shares 10-Q · filed 2025-11-06 | 101.00K shares 10-Q · filed 2025-11-06 | ||
| 2025-06-30 | 657.00K shares 10-Q · filed 2026-08-06 | 859.00K shares 10-Q · filed 2026-08-06 | ||
| 2025-03-31 | 1.06M shares 10-Q · filed 2026-05-07 | |||
| 2024-12-31 | 742.00K shares 10-K · filed 2026-02-26 | |||
| 2024-09-30 | 1.67M shares 10-Q · filed 2025-11-06 | 556.00K shares 10-Q · filed 2025-11-06 | ||
| 2024-06-30 | 0.00 shares 10-Q · filed 2025-08-06 | 0.00 shares 10-Q · filed 2025-08-06 | ||
| 2024-03-31 | 0.00 shares 10-Q · filed 2025-05-07 | |||
| 2023-12-31 | 199.00K shares 10-K · filed 2026-02-26 | |||
| 2023-09-30 | 0.00 shares 10-Q · filed 2024-11-06 | 265.00K shares 10-Q · filed 2024-11-06 | ||
| 2023-06-30 | 797.00K shares 10-Q · filed 2024-07-31 | 0.00 shares 10-Q · filed 2024-07-31 | ||
| 2023-03-31 | 0.00 shares 10-Q · filed 2024-05-02 | |||
| 2022-12-31 | 0.00 shares 10-K · filed 2025-02-26 | |||
| 2022-09-30 | 0.00 shares 10-Q · filed 2023-11-02 | 0.00 shares 10-Q · filed 2023-11-02 | ||
| 2022-06-30 | 0.00 shares 10-Q · filed 2023-08-03 | 0.00 shares 10-Q · filed 2023-08-03 | ||
| 2021-12-31 | 0.00 shares 10-K · filed 2024-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |